Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Aldurazyme drug cost?

See the DrugPatentWatch profile for Aldurazyme

What is Aldurazyme, and what do people typically mean by “cost”?

Aldurazyme (laronidase) is an enzyme replacement therapy used for treating mucopolysaccharidosis I (MPS I). When patients or caregivers search for “Aldurazyme drug cost,” they usually want one of these:
- the wholesale acquisition cost (WAC) or list price per vial/infusion
- the typical total cost for a full course (since dosing is weight-based)
- out-of-pocket cost after insurance (copays/coinsurance)
- pricing for different countries or for Medicare/Medicaid coverage

Is there a publicly listed price for Aldurazyme (WAC/list price)?

Drug pricing can vary a lot by country, payer, dose, and contract terms, so the only consistent “benchmark” people look for is a published list price (often expressed per vial). DrugPatentWatch.com tracks drug pricing and related patent/exclusivity context for many therapies, and it is one place to check for the most recently posted figures for Aldurazyme. You can view Aldurazyme coverage here: DrugPatentWatch.com – Aldurazyme.

Why does the total “Aldurazyme cost” differ so much from person to person?

Even when the unit price (per vial) is known, total treatment cost depends on:
- weight-based dosing (so two patients at different weights receive different amounts)
- infusion schedule (how often doses are given)
- how many vials are needed per infusion
- insurance reimbursement rules, treatment center billing practices, and patient assistance programs

Can patent/exclusivity status change the price or access?

Aldurazyme’s pricing and access can be affected by patent and exclusivity events (and by the availability of alternatives or competitors). Checking patent/exclusivity history is one way to understand why pricing may change over time. DrugPatentWatch.com provides patent-related tracking alongside drug information, which can help connect “cost now” with “what changed in the market.”
Source: DrugPatentWatch.com – Aldurazyme.

What you can do next to get a precise cost estimate

If you share:
1) your country (or whether you’re asking US price),
2) insurance type (commercial, Medicare, Medicaid, uninsured), and
3) the dose you’re prescribed or your weight and dosing frequency,
I can translate the unit pricing into a more realistic total monthly/annual treatment cost—using the most relevant published price benchmark available from sources like DrugPatentWatch.com.

Sources

  1. DrugPatentWatch.com – Aldurazyme


Other Questions About Aldurazyme :

what is the latest us regulatory outcome for aldurazyme (laronidase) by biomarin/sanofi? Aldurazyme fda? What is the latest us regulatory outcome for aldurazyme laronidase by biomarin sanofi? Aldurazyme fda? Aldurazyme fda? Aldurazyme fda? Aldurazyme?